An assessment of ONRAB® oral rabies vaccine persistence in free-ranging mammal populations in Ontario, Canada

Vaccine

Volumn 31, Issue 17, 2013, Pages 2207-2213

  Sobey, K G ^a   Walpole, A A ^a   Rosatte, R ^a   Fehlner Gardiner, C ^b   Donovan, D ^a   Bachmann, P ^a   Coulson, S ^a   Beresford, A ^c   Bruce, L ^a   Kyle, C J ^a  

^a TRENT UNIVERSITY   (Canada)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

^c Artemis Technologies Inc   (Canada)

Author keywords

Free ranging mammals; Human adenovirus; ONRAB ; Ontario; Oral rabies vaccination; Rabies

Indexed keywords

ONRAB; RABIES VACCINE; UNCLASSIFIED DRUG; VIRUS VECTOR; ADENOVIRUS 5, RABIES GLYCOPROTEIN RECOMBINANT VACCINE; DNA VACCINE; RECOMBINANT VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANADA; CARNIVORA; FOX; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABIES VIRUS; RACCOON; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MAMMAL; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RABIES;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; HUMANS; MAMMALS; ONTARIO; RABIES; RABIES VACCINES; RABIES VIRUS; REAL-TIME POLYMERASE CHAIN REACTION; VACCINES, DNA; VACCINES, SYNTHETIC; VIRUS SHEDDING;

EID: 84875850872     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.057     Document Type: Article

References (31)

1. Rupprecht C.E., Smith J.S., Fekadu M., Childs J.E. The ascension of wildlife rabies: a cause for public health concern or intervention. Emerg Infect Dis 1995, 1:107-114.
2. Murray D.L., Kapke C.A., Evermann J.F., Fuller T.K. Infectious disease and the conservation of free-ranging large carnivores. Anim Conserv 1999, 2:241-254.
3. Daszak P., Cunningham A.A., Hyatt A.D. Emerging infectious diseases of wildlife - threats to biodiversity and human health. Science 2000, 287:443-449.
4. Leung A.K., Davies H.D., Hon K.L. Rabies: epidemiology, pathogenesis, and prophylaxis. Adv Ther 2007, 24:1340-1347.
5. Real L.A., Russell C., Waller L., Smith D., Childs J. Spatial dynamics and molecular ecology of North American rabies. J Hered 2005, 96:253-260.
6. Aubert MF, Masson E, Artois M, Barrat J. Oral wildlife rabies vaccination field trials in Europe with recent emphasis on France. In: Rupprecht C, Dietzschold B, Koprowski H, editors. Lyssaviruses. Berlin: Springer-Verlag, 1994. p. 219-43.
7. Pastoret P.P., Brochier B. Epidemiology and control of fox rabies in Europe. Vaccine 1999, 17:1750-1754.
8. Rosatte R., Allan M., Bachmann P., Sobey K., Donovan D., Davies J.C., et al. Prevalence of tetracycline and rabies virus antibody in raccoons, skunks, and foxes following aerial distribution of V-RG baits to control raccoon rabies in Ontario, Canada. J Wildl Dis 2008, 44:946-964.
9. Slate D, Algeo TP, Nelson KM, Chipman RB, Donovan D, Blanton JD, et al. Oral rabies vaccination in North America: opportunities, complexities, and challenges. PLoS Neglect Trop Dis 2009;3(12):e549. doi:10.1371/journalpntd.0000549.
10. Grosenbaugh D.A., Maki J.L., Rupprecht C.E., Wall D.K. Rabies challenge of captive striped skunks (Mephitis mephitis) following oral administration of a live vaccinia-vectored rabies vaccine. J Wildl Dis 2007, 43:124-128.
11. Rupprecht C.E., Charlton K.M., Artois M., Casey G.A., Webster W.A., Campbell J.B., et al. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis 1990, 26:99-102.
12. Fehlner-Gardiner C., Nadin-Davis S., Armstrong J., Muldoon F., Bachmann P., Wandeler A. ERA vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989-2004. J Wildl Dis 2008, 44:71-85.
13. Yarosh O.K., Wandeler A.I., Graham F.L., Campbell J.B., Prevec L. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 1996, 14:1257-1264.
14. Brown L.J., Rosatte R.C., Fehlner-Gardiner C., Taylor J.S., Davies J.C., Donovan D. Immune response and protection in raccoons (Procyon lotor) following consumption of baits containing ONRAB®, a human adenovirus rabies glycoprotein recombinant vaccine. J Wildl Dis 2012, 48:1010-1020.
15. Knowles MK, Nadin-Davis SA, Sheen M, Rosatte R, Mueller R, Beresford A. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species. Vaccine 2009;27:6619-26.
16. Rosatte R.C., Donovan D., Davies J.C., Allan M., Bachmann P., Stevenson B., et al. Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada. J Wildl Dis 2009, 45:363-374.
17. ® rabies vaccine baits to control Arctic-variant rabies in striped skunks in Ontario, Canada. J Wildl Dis 2011, 47:459-465.
18. Mainguy J., Rees E.E., Canac-Marquis P., Bélanger D., Fehlner-Gardiner C., Séguin G., et al. Oral rabies vaccination of raccoons and striped skunks with ONRAB baits: Multiple factors influence field immunogenicity. J Wildl Dis 2012, 48:979-990.
19. ® oral rabies vaccine field performance in raccoons and striped skunks, New Brunswick, Canada, and Maine, USA. J Wildl Dis 2012, 48:157-167.
20. Charlton K.M., Artois M., Prevec L., Campbell J.B., Casey G.A., Wandeler A.I., et al. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch Virol 1992, 123:169-179.
21. Bachmann P., Bramwell R.N., Fraser S.J., Gilmore D.A., Johnston D.H., Lawson K.F., et al. Wild carnivore acceptance of baits for delivery of liquid rabies vaccine. J Wildl Dis 1990, 26:486-501.
22. Johnston D.H., Joachim D.G., Bachmann P., Kardong K.V., Stewart R.E.A., Dix L.M., et al. Aging furbearers using tooth structure and biomarkers. Wild furbearer management and conservation in North America 1987, 228-243. Ontario Trappers Association, North Bay. M. Novak, J. Baker, M. Obbard, B. Mallock (Eds.).
23. Canadian Council on Animal Care (CCAC). Guidelines on: the care and use of wildlife. Ottawa: Canadian Council on Animal Care; 2003.
24. Anderson D.R., Burnham K.P., White G.C., Otis D.L. Density estimation of small-mammal populations using a trapping web and distance sampling methods. Ecology 1983, 64:674-680.
25. Wilhelm J., Pingoud A. Real-time polymerase chain reaction. Chembiochem 2003, 4:1120-1128.
26. Bustin S.A., Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 2004, 15:155-166.
27. Tolson N.D., Charlton K.M., Casey G.A., Knowles M.K., Rupprecht C.E., Lawson K.F., et al. Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein. Arch Virol 1988, 102:297-301.
28. Artois M., Guittre C., Thomas I., Leblois H., Brochier B., Barrat J. Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison. Vaccine 1992, 10:524-528.
29. Thomas I., Brochier B., Languet B., Blancou J., Peharpe D., Kieny M.P., et al. Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route. J Gen Virol 1990, 71:37-42.
30. Henderson H., Jackson F., Bean K., Panasuk B., Niezgoda M., Slate D., et al. Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine. Vaccine 2009, 27:7194-7197.
31. Johnston J.J., Primus T.M., Buettgenbach T., Furcolow C.A., Goodall M.J., Slate D., et al. Evaluation and significance of tetracycline stability in rabies vaccine baits. J Wildl Dis 2005, 41:549-558.